Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

S Banerjee, N Adhikari, SA Amin, T Jha - European journal of medicinal …, 2019 - Elsevier
The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional
regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to …

Recent updates on thienopyrimidine derivatives as anticancer agents

MTM Sayed, RA Hassan, PA Halim… - Medicinal Chemistry …, 2023 - Springer
Thienopyrimidine derivatives hold a unique place between fused pyrimidine compounds.
They are important and widely represented in medicinal chemistry as they are structural …

[HTML][HTML] Dipeptidyl peptidase-IV inhibitory action of Calebin A: an in silico and in vitro analysis

NSS Chalichem, S Jupudi, VR Yasam… - Journal of Ayurveda and …, 2021 - Elsevier
Abstract Background Dipeptidyl peptidase-IV (DPP-IV) inhibitors, the enhancers of incretin
are used for the treatment of diabetes. The non-glycaemic actions of these drugs (under …

Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing

J Liu, Y Zhu, Y He, H Zhu, Y Gao, Z Li… - Journal of …, 2020 - Taylor & Francis
Histone deacetylases (HDACs), a critical family of epigenetic enzymes, has emerged as a
promising target for antitumor drugs. Here, we describe our protocol of virtual screening in …

HDAC8 as a target in drug discovery: function, structure and design

Q Zhao, H Liu, J Peng, H Niu, J Liu, H Xue… - European Journal of …, 2024 - Elsevier
Histone deacetylases (HDACs) have emerged as prominent therapeutic targets in drug
discovery. Among the members of the HDAC family, HDAC8 exhibits distinct structural and …

Recent prospectives of anticancer histone deacetylase inhibitors

SA Abbass, HA Hassan… - Journal of …, 2019 - jabps.journals.ekb.eg
Histone deacetylases (HDACs) are common targets for cancer therapy as they are
expressed in many forms of cancers; several research studies have been introduced …

Conformal prediction of HDAC inhibitors

U Norinder, JJ Naveja, E Lopez-Lopez… - SAR and QSAR in …, 2019 - Taylor & Francis
The growing interest in epigenetic probes and drug discovery, as revealed by several
epigenetic drugs in clinical use or in the lineup of the drug development pipeline, is boosting …

Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening

SM Esther Rubavathy, K Palanisamy… - Journal of …, 2023 - Taylor & Francis
A class I histone deacetylase HDAC8 is associated with several diseases, including cancer,
intellectual impairment and parasite infection. Most of the HDAC inhibitors that have so far …

Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) …

S Khatun, I Dasgupta, R Islam, SA Amin, T Jha… - Molecular Diversity, 2024 - Springer
Histone deacetylases constitute a group of enzymes that participate in several biological
processes. Notably, inhibiting HDAC8 has become a therapeutic strategy for various …

[PDF][PDF] Docking Study, Synthesis, Characterization and Preliminary Cytotoxic Evaluation of New 1, 3, 4-Thiadiazole Derivatives.

NM Mohammed, MH Mohammed… - Journal of Contemporary …, 2023 - iasj.net
Objectives: This study has determined that these newly synthesized analogs hold promise
as potential sources of novel anticancer agents for combating breast cancer. Methods: We …